ROSEN, LEAD INVESTOR ADVISOR, Encourages Investors in Moderna, Inc. to Engage Attorneys in Securities Class Action Before Key Deadline – MRNA

New York, New York–(Newsfile Corp. – August 26, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Moderna, Inc. (NASDAQ: MRNA) securities between January 18, 2023 and June 25, 2024, both dates inclusive (the “Class Period”), of the important Deadline for lead plaintiffs: October 8, 2024.

SO WHAT: If you purchased Moderna securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.